Echinacea Tablet, Orally Disintegrating
FDA Label NDC 60986-2020

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Marco Pharma International Llc. for the product Echinacea (NDC 60986-2020). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients, purpose, otc - keep out of reach of children, dosage, warnings, dosage & administration, inactive ingredients, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients

Coneflower 1XHPUS

Witch Hazel 2XHPUS

Tribasic calcium phosphate  3XHPUS

Goldenseal 4XHPUS

Milkwort 4XHPUS

Silicon dioxide 4XHPUS

Poison Hemlock 4XHPUS

Sodium tetrachloroaurate 5XHPUS

Impure Calcium Carbonate 5XHPUS

Bladder-wrack 5XHPUS

Bushmaster viper venom 8XHPUS

The letters HPUS indicates that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of United Sates.

Purpose

FOR TEMPORARY RELIEF OF SORE THROATS AND LYMPHATIC INFLAMMATION.

Otc - Keep Out Of Reach Of Children

Keep out of reach of children.

Dosage

Adults take 1 tablet three times daily, dissolving on the tongue. For severe symptoms, take one tablet every hour until improvement is felt. Children receive 1/2 tablet as above.

Warnings

If pregnant or breast-feeding, consult a health professional before use.

Dosage & Administration

(Read Suggested Use Section)

Inactive Ingredients

Faex Med. and Lactose

Package Label.Principal Display Panel

Echinacea.jpg

* Please review the disclaimer below.